Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors
Article Date
March 10, 2026
This article is featured on another website.
Go to article
July 31, 2026
What Makes a Modern CRO? Inside HiRO’s Global Growth Story
Part 1 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
July 31, 2026
What Makes a Modern CRO? Inside HiRO’s Global Growth Story
Part 1 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
July 24, 2026
HiRO and Monash Health Sign Site Alliance Agreement at BIO Asia-Taiwan
HiRO Partners with Monash Health to Speed Up Complex Clinical Trials HiRO has formalized a…
July 24, 2026
HiRO and Monash Health Sign Site Alliance Agreement at BIO Asia-Taiwan
HiRO Partners with Monash Health to Speed Up Complex Clinical Trials HiRO has formalized a…